Literature DB >> 12589143

Antibody-mediated accommodation of heart grafts expressing an incompatible carbohydrate antigen.

Muhammad M Mohiuddin1, Haruko Ogawa, Deng-Ping Yin, Jikun Shen, Uri Galili.   

Abstract

BACKGROUND: Accommodation in patients transplanted with ABO incompatible allografts describes a state in which antibodies are produced against the incompatible blood group carbohydrate antigen; however, the graft is not rejected. The present study describes an experimental model for antibody-mediated accommodation of organs expressing incompatible carbohydrate antigens.
METHODS: The model includes alpha1,3galactosyltransferase knockout mice that lack the alpha-gal epitope (Galalpha1-3Galbeta1-4GlcNAc-R), transplanted heterotopically with wild-type (WT) hearts expressing this epitope. The mice are irradiated and receive memory anti-Gal B cells by adoptive transfer. Immunization of these mice with pig-kidney membranes induces the production of large amounts of anti-Gal, which binds specifically to alpha-gal epitopes.
RESULTS: Under the described accommodation protocol, transplanted mice produce anti-Gal that binds to alpha-gal epitopes on endothelial cells of the grafted WT heart; however, the WT hearts continued to function for months. Second WT hearts transplanted into accommodating, anti-Gal producing mice, were not rejected. Anti-Gal in accommodating mice was not cytolytic, whereas anti-Gal in rejecting mice readily induced complement-mediated lysis of cells expressing alpha-gal epitopes. In addition, accommodating mice displayed a preferential increase in the anti-Gal immunoglobulin (Ig)G2b subclass.
CONCLUSIONS: The immune system may be manipulated to accommodate grafts expressing incompatible carbohydrate antigens by preferential production of noncytolytic anticarbohydrate antibodies.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12589143     DOI: 10.1097/01.TP.0000053616.61907.D5

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  12 in total

Review 1.  Accommodation of grafts: implications for health and disease.

Authors:  Amy H Tang; Jeffrey L Platt
Journal:  Hum Immunol       Date:  2007-05-15       Impact factor: 2.850

Review 2.  Accommodation in organ transplantation.

Authors:  Raymond J Lynch; Jeffrey L Platt
Journal:  Curr Opin Organ Transplant       Date:  2008-04       Impact factor: 2.640

3.  C4d deposition without rejection correlates with reduced early scarring in ABO-incompatible renal allografts.

Authors:  Mark Haas; Dorry L Segev; Lorraine C Racusen; Serena M Bagnasco; Jayme E Locke; Daniel S Warren; Christopher E Simpkins; Diane Lepley; Karen E King; Edward S Kraus; Robert A Montgomery
Journal:  J Am Soc Nephrol       Date:  2008-09-05       Impact factor: 10.121

4.  Increased immunogenicity of human immunodeficiency virus gp120 engineered to express Galalpha1-3Galbeta1-4GlcNAc-R epitopes.

Authors:  Ussama Abdel-Motal; Shixia Wang; Shan Lu; Kim Wigglesworth; Uri Galili
Journal:  J Virol       Date:  2006-07       Impact factor: 5.103

Review 5.  Escaping from rejection.

Authors:  Raymond J Lynch; Jeffrey L Platt
Journal:  Transplantation       Date:  2009-12-15       Impact factor: 4.939

6.  Correlation between insulin requirements and anti-galactose antibodies in patients with type 1 diabetes transplanted with neonatal pig islets.

Authors:  R Esquivel-Pérez; A L Rodriguez-Ventura; L M Dorantes; B Ramírez-González; M G López-Santos; R Valdes-Gonzalez
Journal:  Clin Exp Immunol       Date:  2011-04-19       Impact factor: 4.330

7.  ABO Incompatible Kidney Transplantation-Current Status and Uncertainties.

Authors:  Milljae Shin; Sung-Joo Kim
Journal:  J Transplant       Date:  2011-12-10

8.  Clinical xenotransplantation of organs: why aren't we there yet?

Authors:  Muhammad M Mohiuddin
Journal:  PLoS Med       Date:  2007-03-27       Impact factor: 11.069

9.  Intragraft gene expression profile associated with the induction of tolerance.

Authors:  Tomoko Doki; Michael Mello; Dennis Mock; Jacqueline M Evans; Mary Kearns-Jonker
Journal:  BMC Immunol       Date:  2008-02-11       Impact factor: 3.615

Review 10.  Desensitization for solid organ and hematopoietic stem cell transplantation.

Authors:  Andrea A Zachary; Mary S Leffell
Journal:  Immunol Rev       Date:  2014-03       Impact factor: 12.988

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.